Gamifant (emapalumab-lzsg) for Primary Haemophagocytic Lymphohistiocytosis
Gamifant® (emapalumab-lzsg) is an interferon gamma (IFNγ) blocking antibody indicated for the treatment of primary haemophagocytic lymphohistiocytosis (HLH) in paediatric and adult patients.
